Verrica Pharmaceuticals Inc. (VRCA) Financials
VRCA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 97.1 million | 54.8 million |
2023-06-30 | 62.2 million | 6.8 million |
2023-03-31 | 68.6 million | 3.8 million |
2022-12-31 | 44.7 million | 4.7 million |
VRCA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -14.9 million | 9.7 million |
2023-06-30 | -4.7 million | 1.5 million |
2023-03-31 | -4.6 million | 1.1 million |
2022-12-31 | -5.0 million | 1.2 million |
VRCA Net Income
No data available :(
VRCA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 84.3 million | - | 1.4 million |
2023-06-30 | 55.1 million | - | 1.4 million |
2023-03-31 | 60.0 million | - | 1.5 million |
2022-12-31 | 34.3 million | - | 1.5 million |
VRCA Shares Outstanding
VRCA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 65000 | 6.5 million | 20.1 million | - |
2023-06-30 | 59000 | 5.7 million | 5.9 million | - |
2023-03-31 | 11000 | 2.7 million | 4.3 million | - |
2022-12-31 | 66000 | 3.0 million | 3.2 million | - |
VRCA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.9 million | 145000 |
2023-06-30 | 182000 | 136000 |
2023-03-31 | 37000 | 68000 |
2022-12-31 | 68000 | 62000 |
VRCA
Price: $6.76
52 week price:
Earnings Per Share: -1.48 USD
P/E Ratio: -5.10
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 337100
Market Capitalization: 299.1 million